Described herein are oligopeptides useful to inhibit replication in virally infected individuals. In a preferred embodiment of the invention, the oligopeptide is a D-arginine nonamer having N- and C-terminal protecting groups, which, at a 3 uM concentration, exhibits greater than 95% ...http://www.google.fr/patents/US5789531?utm_source=gb-gplus-shareBrevet US5789531 - Peptide-based inhibitors of HIV replication
